News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
Partners

Janelle Hart

Articles by Janelle Hart

Adrenocortical Carcinoma

Adjuvant Mitotane Misses RFS End Point in Adrenocortical Carcinoma

February 27th 2022

Adjuvant mitotane did not yield a significantly reduced risk of recurrence among patients with adrenocortical carcinoma.

Latest Updated Articles

Adjuvant Mitotane Misses RFS End Point in Adrenocortical Carcinoma
Published: February 27th 2022 | Updated:

Trending on Oncology Nursing News

How Using Gender-Neutral Language Can Open Goals of Care Conversations

Physical Activity Supervision Does Not Up QOL in Metastatic Cancer

The “Owners” and “Managers” in the Peer-to-Peer Process: What an APP Should Know

© 2025 MJH Life Sciences^®

All rights reserved.